Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
What is AOD-9604
The SURMOUNT-1 trial demonstrated 20.9% mean body weight reduction with tirzepatide 15mg weekly at 72 weeks, while preclinical 5-amino-1MQ studies showed visceral fat reduction independent of caloric restriction
Current safety data for 5-amino-1MQ appears favorable for short-term use (8-12 week cycles), with no significant toxicity observed in preclinical studies at therapeutic doses
Each shot is administered by a licensed nurse practitioner or trained clinician under medical supervision, right across from the La Grange Road Metra station on the BNSF line
US$ 21.47
US$ 24.20
US$ 22.47
